Zobrazeno 1 - 10
of 646
pro vyhledávání: '"Jorge J, Castillo"'
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Not available.
Externí odkaz:
https://doaj.org/article/92c7b80d933d47538ecd251fbea032ae
Autor:
María Elena Cabrera, Camila Peña, Valeska Vega, Hernán Rojas, Alvaro Pizarro, Christine Rojas, Susana Calderon, Jacqueline Oliva, Cecilia Hales, Bernardita Rojas, Marvila Intriago, Marisa Capurro, M. Luisa Gonzalez, Jorge J. Castillo
Publikováno v:
Cancer Reports, Vol 7, Iss 9, Pp n/a-n/a (2024)
ABSTRACT Background Follicular lymphoma (FL) is the most common indolent non‐Hodgkin lymphoma (NHL) in the United States and Europe. However, data on FL from Latin America are scant. Aims This study aims at better understand the clinical features,
Externí odkaz:
https://doaj.org/article/28033eb3a9e54b2bbc55ef8f66d943ed
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 16, Iss 1 (2024)
Waldenström macroglobulinemia (WM) is an infrequent variant of lymphoma, classified as a B-cell malignancy identified by the presence of IgM paraprotein, infiltration of clonal, small lymphoplasmacytic B cells in the bone marrow, and the MYD88 L265P
Externí odkaz:
https://doaj.org/article/83e1a80094f944cb857c8ec0a5e73d97
Waldenström macroglobulinemia (WM) is a rare lymphoplasmacytic lymphoma characterized by the presence of an immunoglobulin M (IgM) monoclonal protein. WM is a chronic, indolent disease, which can remain undiagnosed for years. A better understanding
Autor:
Joseph Alburqueque-Melgarejo, Brady Beltrán-Gárate, Eugenio A. Palomino-Portilla, Ma. del Pilar Quiñones-Ávila, Luis Villela, Jorge J. Castillo, Jhony A. De la Cruz-Vargas
Publikováno v:
Gaceta Mexicana de Oncología, Vol 23, Iss 91 (2024)
Nasal-type extranodal natural killer (NK)/T cell lymphoma is a rare type of highly aggressive lymphoma, accounting for approximately 10% of non-Hodgkin lymphomas and 30% of extranodal lymphomas. This article discusses the case of a patient who presen
Externí odkaz:
https://doaj.org/article/1fa74f1469db485d9718e6f698c4a3b0
Autor:
Jorge J Castillo, Edwin C Kingsley, Mohit Narang, Habte A Yimer, Constantin A Dasanu, Jason M Melear, Morton Coleman, Charles M Farber, Jonah Shulman, Emily H Mantovani, Xiaowei Zhang, Aileen Cohen, Jane Huang
Publikováno v:
eJHaem, Vol 4, Iss 1, Pp 301-304 (2023)
Externí odkaz:
https://doaj.org/article/61318e5dc11945ce8ecb239e81fc2c4b
Publikováno v:
Hemato, Vol 3, Iss 4, Pp 731-741 (2022)
Waldenström macroglobulinemia (WM) is a rare lymphoplasmacytic disorder characterized by an IgM paraprotein. The clinical presentation of WM varies and can include common manifestations such as anemia and hyperviscosity, in addition to less common f
Externí odkaz:
https://doaj.org/article/df053e0eb31b4eb78e97035deb58a1c0
Publikováno v:
Hemato, Vol 3, Iss 4, Pp 758-770 (2022)
Bing–Neel syndrome (BNS) is a rare neurological complication of Waldenström macroglobulinaemia. We highlight key issues in clinical presentation, diagnosis, and treatment while focusing on new and emerging therapies available for patients diagnose
Externí odkaz:
https://doaj.org/article/797bf651db2b47a593055d468100f8a1
Autor:
Eric Durot, Cécile Tomowiak, Elise Toussaint, Pierre Morel, Dipti Talaulikar, Prashant Kapoor, Jorge J. Castillo, Alain Delmer
Publikováno v:
Hemato, Vol 3, Iss 4, Pp 650-662 (2022)
Histological transformation (HT) to an aggressive lymphoma results from a rare evolution of Waldenström macroglobulinemia (WM). A higher incidence of transformation events has been reported in MYD88 wild-type WM patients. HT in WM can be histologica
Externí odkaz:
https://doaj.org/article/16741abba5384a3794c2bd6533ac4da0
Autor:
Jorge J. Castillo, Shayna Sarosiek, Catherine A. Flynn, Carly Leventoff, Megan Little, Timothy White, Kirsten Meid, Steven P. Treon
Publikováno v:
eJHaem, Vol 3, Iss 3, Pp 927-929 (2022)
Abstract The hematopoietic cell kinase (HCK) regulates BTK activation and represents a potential therapeutic target in Waldenstrom macroglobulinemia (WM). We investigated dasatinib, a potent HCK inhibitor, in patients with WM progressing on ibrutinib
Externí odkaz:
https://doaj.org/article/2b3ae86ac79d4f00af7997d2bc26306a